trimethylaminuria

Wikipedia preview

出典(authority):フリー百科事典『ウィキペディア（Wikipedia）』「2013/03/08 03:18:56」(JST)

wiki en

[Wiki en表示]

C.B disease
Classification and external resources
Trimethylamine
ICD-10	E88.8
ICD-9	270.8
OMIM	602079
DiseasesDB	4835
GeneReviews	Trimethylaminuria

Trimethylaminuria (TMAU), also known as fish odor syndrome or fish malodor syndrome, is a rare metabolic disorder that causes a defect in the normal production of the enzyme flavin containing monooxygenase 3 (FMO3). When FMO3 is not working correctly or if not enough enzyme is produced, the body loses the ability to properly convert trimethylamine (TMA) from precursor compounds in food digestion into trimethylamine oxide (TMAO) through a process called N-oxygenation. Trimethylamine then builds up and is released in the person's sweat, urine, and breath, giving off a strong fishy odor or strong body odor.

History

The first clinical case of TMAU was described in 1970.

Symptoms

Trimethylamine builds up in the body of patients with trimethylaminuria. The trimethylamine gets released in the person's sweat, urine, reproductive fluids, and breath, giving off a strong fishy or body odor. Some people with trimethylaminuria have a strong odor all the time, but most have a moderate smell that varies in intensity over time. Individuals with this condition do not have any physical symptoms, and typically appear healthy.

The condition seems to be more common in women than men, for unknown reasons. Scientists suspect that female sex hormones, such as progesterone and estrogen, aggravate symptoms. There are several reports that the condition worsens around puberty. In women, symptoms can worsen just before and during menstrual periods, after taking oral contraceptives, and around menopause.

This odor varies depending on many known factors, including diet, hormonal changes, stress level, amount of sweat, other odors in the space, and individual sense of smell.

Diagnosis

Measurement of urine for the ratio of trimethylamine to trimethylamine oxide is the standard screening test. A blood test is available to provide genetic analysis. The prominent enzyme responsible for TMA N-oxygenation is coded by the FMO3 gene.

A similar test can be used to identify carriers of this condition - those individuals who carry one copy of a mutated gene but do not have symptoms. In this case, the person would be given a high dose of choline (one of the precursors of trimethylamine) and then have their urine tested for elevated levels of trimethylamine.

Treatment

There is no known cure or treatment for the disorder. People affected by the disorder live relatively normal lives by managing their symptoms and with counseling. When the condition is suspected or known to occur in a family, genetic testing can be helpful in identifying the specific individuals who have or carry the disorder.

Ways of reducing the fishy odor may include:

• Avoiding foods such as egg yolks, legumes, red meats, fish, beans and other foods that contain choline, carnitine, nitrogen, sulfur and lecithin
• Taking low doses of antibiotics such as neomycin and metronidazole in order to reduce the amount of bacteria in the gut
• Using slightly acidic detergent with a pH between 5.5 and 6.5

Additionally, at least one study has suggested that daily intake of the supplements activated charcoal and copper chlorophyllin may improve the quality of life of individuals afflicted with TMAU by helping their bodies to oxidize and convert TMA to the odorless N-oxide (TMAO) metabolite. Study participants experienced subjective reduction in odor as well as objective reduction in TMA and increase in TMAO concentration measured in their urine. The study's success rates varied:

• 85% of test participants experienced complete loss of detectable "fishy" odor
• 10% experienced some reduction in detectable odor
• 5% did not experience any detectable odor reduction

Genetics

Trimethylaminuria has an autosomal recessive pattern of inheritance.

Most cases of trimethylaminuria appear to be inherited in an autosomal recessive pattern, which means two copies of the gene in each cell are altered. The parents of an individual with an autosomal recessive disorder are carriers of one copy of the altered gene. Carriers may have mild symptoms of trimethylaminuria or experience temporary episodes of fish-like body odor.

Mutations in the FMO3 gene, which is found on the long arm of chromosome 1, cause trimethylaminuria. The FMO3 gene makes an enzyme that breaks down nitrogen-containing compounds from the diet, including trimethylamine. These compounds are produced by bacteria in the intestine as they digest proteins from eggs, meat, soy, and other foods. Normally, the FMO3 enzyme converts fishy-smelling trimethylamine into trimethylamine N-oxide which has no odor. If the enzyme is missing or its activity is reduced because of a mutation in the FMO3 gene, trimethylamine is not broken down and instead builds up in the body. As the compound is released in a person's sweat, urine, and breath, it causes the strong odor characteristic of trimethylaminuria. Researchers believe that stress and diet also play a role in triggering symptoms.

There are more than 40 known mutations associated with TMAU. Loss-of-function mutations, nonsense mutations, and missense mutations are three of the most common. Nonsense and missense mutations cause the most severe phenotypes.

Although FMO3 mutations account for most known cases of trimethylaminuria, some cases are caused by other factors. A fish-like body odor could result from an excess of certain proteins in the diet or from an increase in bacteria in the digestive system. A few cases of the disorder have been identified in adults with liver damage caused by hepatitis.

In 2007 the evolution of the FMO3 gene was studied, including the evolution of some mutations associated with TMAU.

See also

• Dimethylglycinuria another known cause of fish odor
• Urinary tract infections can give false positive TMA urinalysis results
• Dimethylsulfidemia another metabolic/blood borne malodor condition

References

This article incorporates public domain text from The U.S. National Library of Medicine and The National Human Genome Research Institute

UpToDate Contents

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.

• 1. 先天性代謝異常：疫学、病因、および臨床的特徴 inborn errors of metabolism epidemiology pathogenesis and clinical features
• 2. 口臭 bad breath

English Journal

• Fish Malodour syndrome in a child.

• Oliveira A1, Faria A1, Oliva M1.
• BMJ case reports.BMJ Case Rep.2015 Apr 13;2015. pii: bcr2014207002. doi: 10.1136/bcr-2014-207002.
• Body odour can be a manifestation of several metabolic diseases. Diagnosis may be difficult because the disease is often unknown to the doctor. We present a child observed in a general paediatric clinic for bad body odour after eating fish. Given the suspicion of trimethylaminuria, molecular study o
• PMID 25870212

• Regulation of flavin-containing mono-oxygenase (Fmo3) gene expression by steroids in mice and humans.

• Esposito T, Varriale B, D'Angelo R, Amato A, Sidoti A.
• Hormone molecular biology and clinical investigation.Horm Mol Biol Clin Investig.2014 Dec;20(3):99-109. doi: 10.1515/hmbci-2014-0012.
• Abstract Flavin-containing mono-oxygenases (FMOs) are a family of microsomal chemical- and drug-metabolizing enzymes. FMO3 is a major FMO form in adult mouse and human liver. FMO3 mutations have been associated with the incidence and severity of trimethylaminuria (TMAU), a metabolic disorder charact
• PMID 25460299

• Archaea and the human gut: new beginning of an old story.

• Gaci N1, Borrel G1, Tottey W1, O'Toole PW1, Brugère JF1.
• World journal of gastroenterology : WJG.World J Gastroenterol.2014 Nov 21;20(43):16062-78. doi: 10.3748/wjg.v20.i43.16062.
• Methanogenic archaea are known as human gut inhabitants since more than 30 years ago through the detection of methane in the breath and isolation of two methanogenic species belonging to the order Methanobacteriales, Methanobrevibacter smithii and Methanosphaera stadtmanae. During the last decade, d
• PMID 25473158

Japanese Journal

• Epilepsy and trimethylaminuria : A new case report and literature review

• Brain & development 33(7), 593-596, 2011-08-01
• NAID 10031121958

• 日本人トリメチルアミン尿症患者の食材工夫による緩和療法研究

• 日本薬物動態学会年会講演要旨集 25(0), 196-196, 2010
• NAID 130004639901

• Bonitos with Low Content of Malodorous Trimethylamine as Palliative Care for Self-reported Japanese Trimethylaminuria Subjects

• Drug metabolism and pharmacokinetics 24(6), 549-552, 2009-12-25
• NAID 10027119731

Related Pictures